Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Downgrades Aviva plc (AV) to Hold
-
Streetinsider.com's Hot Lunchtime Reads 08/13: (FB) (GM) (SINA) (PSX) (IOC) (JCP)
-
Notable Analyst Rating Changes 08/13: (GOOG) (IP) (CPB) Upgraded; (P) (TC) (KO) Downgraded
-
Canaccord Genuity Morning Coffee on Yahoo! (YHOO): Swing and a Marissa...
-
Canaccord Genuity Morning Coffee on Nvidia (NVDA): Chip, Chip, Hooray!
-
Canaccord Genuity Morning Coffee on JPMorgan (JPM): Insufficient Funds
-
Canaccord Genuity Morning Coffee on Groupon (GRPN): Why is Every Second Deal for Yoga Lessons?
-
Canaccord Genuity Morning Coffee on Chesapeake Energy (CHK): Turning Up The Heat
-
Canaccord Genuity Maintains a 'Buy' on Ultra Petroleum (UPL); Price Target Cut on Rollover
-
Canaccord Genuity Reiterates a 'Buy' on Solta Medical (SLTM); Follow-on Gives Push to MRX Milestone
-
UPDATE: Canaccord Genuity Upgrades Tranzyme (TZYM) to Buy; Raising Chances of TZP-102 Success
-
Canaccord Genuity Maintains a 'Hold' on Darling International (DAR); Street Assumes Diamond Green Diesel Launch
-
Canaccord Genuity Raises Price Target on Annie's, Inc. (BNNY); One of the Strongest Brands in Natural/Organic Industry
-
UPDATE: Canaccord Genuity Upgrades Bed Bath & Beyond (BBBY) to Buy; Recent Dip Provides Opportunity; Cost Plus Provides Extra Boost
-
UPDATE: Canaccord Genuity Starts SodaStream International (SODA) at Hold; Opportunities Begin to Bubble
-
Sunshine Heart (SSH) Prices 2.88M Offering at $7/Share
-
Canaccord Genuity Starts RDA Microelectronics (RDA) at Buy
-
Canaccord Genuity Positive on Amarin (AMRN) NCE Status; Trims PT
-
Low Visibility Prompts Canaccord to Cut Price Target on Medicis (MRX)
-
Buy Insulent Corp. (PODD) on Weakness - Canaccord Genuity
-
Canaccord Ups Price Target on XOMA, Ltd. (XOMA), sees "Progress" in Trials
-
Fuel Systems Solutions (FSYS) Shares "Washed Out", Hold, PT to $19 - Canaccord
-
Canaccord Genuity Stamps $40 PT on Foot Locker (FL), Channel Checks Point to Strong Comps
-
Canaccord Genuity Downgrades Kinross Gold (KGC) to Hold
-
Canaccord Genuity Maintains Hold and Raises Price Target on ISIS Pharmaceuticals (ISIS)
-
Canaccord Genuity Boosts Price Target on Black Diamond (BDE)
-
Canaccord Genuity Calls Leap Wireless (LEAP) Dead Money
-
Pre-Open Movers 8/7: (USHS) (BSFT) (FOSL) Higher; (WMS) (LEAP) (NIHD) Lower (more...)
-
UPDATE: Canaccord Genuity Upgrades Coach (COH) to Buy, Industry-Leading ROIC at a Discount
-
Streetinsider.com's Hot Lunchtime Reads 08/06: (AMRN) (MTG) (TGT) (P) (MNTA) (AAPL)
-
Apple (AAPL) Accounts for 71% of Q2 Global Handset Revs; Samsung, Android Devices Should Gain Share in Q3 - Analyst
-
Canaccord Genuity Comments on Momenta Pharmaceuticals (MNTA)
-
Canaccord Genuity Comments on Warner Chilcott (WCRX)
-
Canaccord Genuity Reiterates Hold on Protalix BioTherapeutics (PLX)
-
Canaccord Genuity Trims Target on Renewable Energy Group (REGI) Ahead of Results
-
Canaccord Genuity Morning Coffee on Knight Capital Group (KCG): Joyce to the World: "All Hands on Deck!"
-
Canaccord Genuity Morning Coffee on SPDR Retail ETF (XRT): Shop 'til You Drop!
-
Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); A Little Reaction or Side Effect?
-
Canaccord Genuity Maintains a 'Buy' on Synageva BioPharma (GEVA); SBC-102 P1/2 Extension Data Next
-
UPDATE: Correction - Canaccord Genuity Maintains a 'Buy' on Incyte (INCY); Q2 and Guidance Raises Several Questions
-
Canaccord Genuity Reiterates a 'Hold' on Momenta Pharmaceuticals (MNTA); Q2: First Clarity on Baxter (BAX) Biosimilars Deal
-
Canaccord Genuity on AVEO Pharmaceuticals (AVEO): FDA Concern on OS Rrend May Delay TIVO Filing
-
Canaccord Genuity Maintains a 'Hold' on Volcano Corp. (VOLC); Staying on Sidelines
-
Canaccord Genuity Maintains a 'Buy' on Obagi Medical Products (OMPI); Resurgence From Texas To Take Longer
-
Canaccord Genuity on AtriCure Inc. (ATRC): Bottom Line - Buy on Weakness
-
Canaccord Genuity Raising PT and Estimates on ResMed (RMD); Solid Q4
-
Canaccord Genuity Maintains a 'Hold' on Rubicon Technology (RBCN); Q2 Beat, But Waiting on Adoption
-
Canaccord Genuity Maintains a 'Buy' on Xylem (XYL); Adjusting Estimates Again
-
Canaccord Genuity Maintains a 'Hold' on MaxLinear (MXL); Story Intact Despite Revision
-
Canaccord Genuity Maintains a 'Buy' on DIRECTV (DTV); Bear Food

